ANI Pharmaceuticals ANIP Accounts Payable

Accounts Payable at other companies

ViatrisVTRS

$1.73B-3.1%

AnaptysBio, Inc.ANAB

$7.52M+22.8%

Eton Pharmaceuticals, Inc.ETON

$13.49M+177%

Aurinia PharmaceuticalsAUPH

$1.74M-47.6%

PVL

Palvella TherapeuticsPVLA

$5.44M+22.6%

Zevra Therapeutics, Inc.ZVRA

$13.96M-11.9%

FAQ

What is ANI Pharmaceuticals's accounts payable?

ANI Pharmaceuticals (ANIP) reported accounts payable of $73.83M in Q2 2026.

How has ANI Pharmaceuticals's accounts payable changed year-over-year?

ANI Pharmaceuticals's accounts payable increased by 35.3% year-over-year, from $54.57M to $73.83M.

What is the long-term trend for ANI Pharmaceuticals's accounts payable?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's accounts payable has grown at a 40.9% compound annual growth rate (CAGR), from $11.26M to $62.58M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.